Three-dimensional-software developer Vital Images has renewed its U.S. and international marketing distribution agreement with Toshiba Medical Systems of Tochigi, Japan.
Toshiba will continue to offer the Plymouth, MN-based vendor’s Vitrea 2 software through its subsidiaries and distributors in more than 50 nations in North and South America, Europe, the Middle East, Africa, Australia, and Asia (except Japan). Toshiba has been offering Vitrea software since 2000 as its 3-D product of choice for customers purchasing its Aquilion and Asteion CT scanners, Vital Images said.
The new agreement is effective through December 31, 2004, and can be renewed by mutual consent. It includes a minimum worldwide revenue commitment from Toshiba of approximately $7.7 million.
For the first nine months of 2003, Toshiba accounted for $9.8 million in sales to Vital Images, a figure that represented 45% of Vital Images’ revenues. That compared with $5.5 million, or 37% of Vital Images’ revenues, for the first nine months of 2002.
By AuntMinnie.com staff writers
December 15, 2003
Related Reading
Vital Images moving into lung analysis with R2 Technology, December 3, 2003
Vital Images shows Q3 gains, October 21, 2003
Vital Images, Mirada Solutions close deal, September 4, 2003
Vital Images, McKesson ink pact, July 8, 2003
Copyright © 2003 AuntMinnie.com
![Images show the pectoralis muscles of a healthy male individual who never smoked (age, 66 years; height, 178 cm; body mass index [BMI, calculated as weight in kilograms divided by height in meters squared], 28.4; number of cigarette pack-years, 0; forced expiratory volume in 1 second [FEV1], 97.6% predicted; FEV1: forced vital capacity [FVC] ratio, 0.71; pectoralis muscle area [PMA], 59.4 cm2; pectoralis muscle volume [PMV], 764 cm3) and a male individual with a smoking history and chronic obstructive pulmonary disorder (COPD) (age, 66 years; height, 178 cm; BMI, 27.5; number of cigarette pack-years, 43.2, FEV1, 48% predicted; FEV1:FVC, 0.56; PMA, 35 cm2; PMV, 480.8 cm3) from the Canadian Cohort Obstructive Lung Disease (i.e., CanCOLD) study. The CT image is shown in the axial plane. The PMV is automatically extracted using the developed deep learning model and overlayed onto the lungs for visual clarity.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/03/genkin.25LqljVF0y.jpg?auto=format%2Ccompress&crop=focalpoint&dpr=2&fit=crop&h=167&q=70&w=250)
